GBI Biomanufacturing is a full-service contract development and manufacturing organisation (CDMO) based in Florida, specialising in biopharmaceutical production for complex biologic therapeutics.

GBI offers a comprehensive suite of services, including upstream processing, cell culture development, DSP purification, cGMP clinical and commercial manufacturing, bioconjugation, aseptic fill and finish, stability testing, and analytical method development. Their approach is tailored to each client’s needs, ensuring efficient and cost-effective solutions for drug development and manufacturing.

With years of expertise and a commitment to innovation, GBI is a trusted partner for the development and production of cutting-edge biologics.